Regulus Therapeutics Inc (RGLS)
2.65
-0.04
(-1.49%)
USD |
NASDAQ |
May 03, 16:00
2.65
0.00 (0.00%)
After-Hours: 20:00
Regulus Therapeutics Total Return Level: 2.69 for May 2, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 02, 2024 | 2.69 |
May 01, 2024 | 2.51 |
April 30, 2024 | 2.30 |
April 29, 2024 | 2.52 |
April 26, 2024 | 2.42 |
April 25, 2024 | 2.27 |
April 24, 2024 | 2.22 |
April 23, 2024 | 2.26 |
April 22, 2024 | 2.20 |
April 19, 2024 | 2.13 |
April 18, 2024 | 2.22 |
April 17, 2024 | 2.34 |
April 16, 2024 | 2.56 |
April 15, 2024 | 2.78 |
April 12, 2024 | 2.80 |
April 11, 2024 | 2.78 |
April 10, 2024 | 2.62 |
April 09, 2024 | 2.70 |
April 08, 2024 | 2.67 |
April 05, 2024 | 2.54 |
April 04, 2024 | 2.52 |
April 03, 2024 | 2.61 |
April 02, 2024 | 2.72 |
April 01, 2024 | 2.80 |
March 28, 2024 | 2.88 |
Date | Value |
---|---|
March 27, 2024 | 2.88 |
March 26, 2024 | 2.845 |
March 25, 2024 | 2.82 |
March 22, 2024 | 2.685 |
March 21, 2024 | 2.78 |
March 20, 2024 | 2.50 |
March 19, 2024 | 2.385 |
March 18, 2024 | 2.36 |
March 15, 2024 | 2.11 |
March 14, 2024 | 2.445 |
March 13, 2024 | 2.43 |
March 12, 2024 | 2.36 |
March 11, 2024 | 1.38 |
March 08, 2024 | 1.39 |
March 07, 2024 | 1.42 |
March 06, 2024 | 1.50 |
March 05, 2024 | 1.48 |
March 04, 2024 | 1.49 |
March 01, 2024 | 1.49 |
February 29, 2024 | 1.47 |
February 28, 2024 | 1.49 |
February 27, 2024 | 1.505 |
February 26, 2024 | 1.42 |
February 23, 2024 | 1.46 |
February 22, 2024 | 1.53 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.7929
Minimum
Mar 27 2023
19.60
Maximum
Mar 12 2021
5.292
Average
4.472
Median
Total Return Level Benchmarks
ACADIA Pharmaceuticals Inc | 17.07 |
ADMA Biologics Inc | 6.73 |
FibroGen Inc | 1.13 |
Protara Therapeutics Inc | 2.89 |
Amylyx Pharmaceuticals Inc | 2.00 |